Zura Bio (ZURA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Zura Bio Limited (ZURA) specializes in developing potent treatments for systemic inflammation by utilizing unique cytokine suppression. This EV/EBITDA market price chart, with a value of 0.00, links these advantages to the plan for capturing the targeted immunology niche. The biotech's successful development is driven by strong management with deep expertise, as evidenced by high investor confidence in the company's current share price.
Zura Bio Ltd - analytical breakdowns and key metrics (ZURA)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ZURA - Final Profit|Projected Future Earnings Zura Bio Limited|ZURA - P/E Multiple|Projected Price to Earnings Zura Bio|ZURA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Zura Bio|ZURA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Zura Bio|ZURA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months zurabio.com|ZURA - Earnings per share growth rate in current year|Expected earnings per share growth for next year Zura Bio Limited
Initial company analysis:Zura Bio (ZURA)
The EV/EBITDA multiple determines the value of a business relative to its operating profit, neutralizing the impact of tax regimes and debt loads. It measures the real price of an asset accounting for leverage, allowing for the identification of overvaluation during periods of market optimism. By analyzing the EV/EBITDA multiple trend, an investor assesses the capital stability of Zura Bio Limited. This is critical for a biopharmaceutical innovator whose ambitious developments in targeted therapies require significant investment.
Direct competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio DNTH|PHVS (Pharvaris N.V.) - Enterprise Value to EBITDA Ratio|AbCellera (ABCL) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|PGEN: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PHAR|EV/EBITDA Multiple Nektar Corp (NKTR)|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ZBIO|Immunome - EV/EBITDA Multiple|GOSS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KALV: EV/EBITDA Multiple|SEPN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Company Value to EBITDA savarapharma.com SVRA|Enterprise Value to EBITDA Ratio RIGL (Rigel Pharmaceuticals, Inc.)|ANAB (AnaptysBio Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|enGene Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT Therapeutics - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|Enterprise Value to Operating Income Before Depreciation Ratio THTX|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Eledon Pharmaceuticals Inc. (ELDN) - Company Value to EBITDA|Agenus Inc - EV/EBITDA Multiple|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio ADAG (Adagene Inc.)|Enterprise Value to EBITDA Ratio IMA|EV/EBITDA Multiple Shattuck Therapeutics|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XFOR|ACET: EV/EBITDA Multiple|Celularity - Business Value to Operating Income Before Depreciation|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple barinthusbio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|Q32 Bio Corp - EV/EBITDA Multiple|GOVX - EV/EBITDA Multiple|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc - Business Value to Operating Income Before Depreciation|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|XTL Bio (XTLB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM - Enterprise Value to EBITDA Ratio|ADTX: Enterprise Value to EBITDA Ratio|GRI - EV/EBITDA Multiple|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation HIND|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Indaptus Therapeutics Inc INDP|Enterprise Value to EBITDA Ratio SCNI (Scinai)|CALI: Company Value to Operating Income Before Depreciation Ratio|Affimed N.V. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Allakos Inc ALLK|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp (OCEA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio TCBP|THRD: Business Value to Operating Income Before Depreciation
